New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
08:31 EDTXNPTXenoPort to mail letter to shareholders
XenoPort announced that it is mailing a letter to stockholders in connection with the company’s upcoming Annual Meeting, which will be held on June 11. In the letter, XenoPort urges stockholders to protect the value of their investment by voting “FOR ALL” of XenoPort’s nominees to the Board of Directors on the WHITE proxy card. Highlights of the letter include: XenoPort is advancing XP23829; XenoPort is building value in HORIZANT; XenoPort’s Board is committed to fully realizing the value of XenoPort’s assets – for the benefit of all XenoPort stockholders; Clinton is waging a misleading proxy campaign to replace three of XenoPort’s proven, highly-qualified directors with three of its own handpicked nominees; and XenoPort believes Clinton’s uninformed agenda would fail to maximize the value of XenoPort’s assets. XenoPort believes Clinton’s agenda is short-term focused and puts at risk the opportunity for long-term value creation
News For XNPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 28, 2015
09:24 EDTXNPTJefferies sees Pharma M&A continuing, lists 22 possible targets
Jefferies analyst David Steinberg believes the M&A wave in the Pharmaceuticals space that began in 2005 can continue as the key drivers remain largely intact. In a note titled "Who is Next? The Feeding Frenzy in Specialty Pharmaceuticals," Steinberg sees deals continuing amid cheap debt, the push for lower corporate taxes and investors rewarding many acquirers for their transactions. He points out there are now around 100 publicly traded Specialty Pharmaceutical companies following the recent life sciences IPO boom. Potential takeover targets, according to Steinberg, include Valeant (VRX), Shire (SHPG), Perrigo (PRGO), Zoetis (ZTS), Mallinckrodt (MNK), Jazz Pharmaceuticals (JAZZ), United Therapeutics (UTHR), Pacira (PCRX), Indivior, Insys Therapeutics (INSY), The Medicines Co. (MDCO), Depomed (DEPO), Spectrum (SPPI), KYTHERA (KYTH), Revance (RVNC), XenoPort (XNPT), Mylan (MYL), Akorn (AKRX), Impax (IPXL), Amphastar Pharmaceuticals (AMPH), Anacor (ANAC) and BioDelivery Sciences (BDSI).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use